ONCOLOGY SOLUTIONS FOR ALL SAMPLE TYPES. Experts in FFPE AND LIQUID BIOPSIES
Your genomics partner in oncology
Answer any DNA and RNA related question
Research
Precision oncology
Clinical trials
Safety testing
Our GENOMICS Solutions for ONCOLOGY
We provide all the solutions you will need
Variants
New or actionable
DNA variants identified
via:
Read more
- Whole genome sequencing (WGS)
- Exome sequencing (WES)
- Comprehensive genomic cancer profiling (CGP) of 591 cancer genes
- Genome wide microarrays
- Analyses of single markers or genes
- Custom panels and assays
- Use FFPE, plasma and any other sources
Transcript and RNA
Profile you tumour sample for fusion transcripts, differential gene expression, splice variants and neoantigens with:
Read more
- Stranded library sequencing
- RNA exome sequencing
- FFPE expression analyses
- Whole transcriptome arrays and biobank screenings
- Single gene and marker expression testing
- miRNA profiling
Structural variants
Utilising numerous NGS and Microarray tools, deci-
pher:
Read more
- Chromosomal rearrangements
- Fusion genes
- Copy number variations
- Telomeric aberrations
- … (CGH)
- Loss of heterozygosity (LOH)
Biomarkers
Identification and
follow up of
biomarkers by:
Read more
- Custom dPCR and qPCR assays
- Liquid biopsy service
- Actionable mutation panel (Oncotarget) (registered ® ???)
- Ultra-high throughput and low cost expression profiling
- SNP and CGH microarrays
- Genome and exome and transcriptome sequencing
- Comprehensive genomic tumour profiling (Oncoprofiling -591 genes) ® ???
Safety testing
Read more
- residual host cell DNA testing
- adventitious virus testing,
- vector shedding, RCR, RCV, VCN testing
- Cell line authentication and mycoplasma check service
- Testing modified genomes (e.g.: CAR-T cells)
- GLP accredited solutions, GCP compliant services
- Toxicology screening solutions
Liquid biopsy
Understanding the cancer patient analysing cfDNA, CTC aDNA and cf-miRNA by
Read more
- Hotspot actionable variant genotyping (Oncotarget ®)
- Custom qPCR and dPCR assays
- Low pass whole genome sequencing
- Whole genome and exome sequencing
- Comprehensive genomic cancer profiling (CGP) of 591 cancer genes
- Custom NGS panels
- Targeted bisulfit sequencing
Precision oncology
helping to improve patients outcome
Read more
- Comprehensive genomic cancer profiling (CGP) of 591 cancer genes
- Exome sequencing (WES)
- Whole genome sequencing (WGS)
- hotspot actionable variant genotyping (Oncotarget ®)
- fusion transcripts and gene expression profiling
- Structural variant detection (SVs, CNVs)
- Liquid biopsy solutions
- Custom assay development, like minimal residual disease (MRD) testing
Clinical trials
All services are available GCP compliant
Read more
- Sanger, NGS, dPCR and qPCR services
- Logistic and central laboratory services
- Inclusion criteria testing
- Safety testing, like vector shedding, RCR, RCV, VCN, residual host cell DNA and adventitious virus testing,
- Cell line authentication and mycoplasma check service
Epigenetics
Decode the epigenome in various ways:
Read more
- Genome wide methylation array – EPIC
- Whole genome bisulfit sequencing
- Reduced representation bisulfit sequencing
- Target bisulfit sequencing from liquid biopsies
- Custom targeted assay development
Beyond genomics
Complete Eurofins Group Oncology Service World
Read more
- Pathology, histology, immunohistochemistry, cell line and compound testing, CDMO service, biopharma product testing and central lab
- services, Medical diagnostic laboratory service
Full scalability
100%
From one to thousands of samples.
Don’t be afraid to think big!
tackle your challenges
Our technologies
We provide everything you need:
- Next-generation sequencing (NGS, Illumina)
- Microarrays (all Illumina and Thermo Fisher platforms)
- qPCR / dPCR
- Sanger sequencing
- Oligo synthesis
- Gene synthesis
- DNA / RNA extractions
- Bioinformatics
- Bio-banking
- Sampling kits supply and logistics network
lean optimised workflows
Make full use of our high capacities, high reliability, and fastest turnaround time
- 1 business day qPCR/dPCR biomarker testing
- 5 business days microarray service
- 9 business days exome
- 9 business days comprehensive genomic profiling
- 10 business days whole human genome
- Fastes logistics solutions
- Shortest response time
Quality is our second name
Work with a fully certified partner
ISO 17025
Guaranteed confidentiality and integrity of testing data.
Testing results are recognised by authorities and customs, etc. for the release of pharmaceuticals and food and feed, in the case of legal implications.
ISO 13485
Full documentation and traceability of production processes.
Compliance with regulatory requirements in regard to EU, US and other national directives about medical devices, in vitro Diagnostics or medicinal products.
Quality management system is in line with the FDA QSR standards.
ISO 9001
Short production times due to highly optimised and structured processes.
Well trained, competent and highly qualified personnel.
Fully documented processes.
Effective complaint and CAPA management.
GCLP
Guaranteed confidentiality and integrity of clinical trial data.
Full protection of patient rights, safety and well-being.
Full compliance with GCLP regulatory requirements.
Acceptance of clinical study data by regulatory authorities in EU, US and worldwide.
GLP
Full traceability of GLP study data.
GLP compliant archiving of study data and records.
Full compliance with GLP regulatory requirements (OECD, EMA, US-FDA, US-EPA).
Acceptance of non-clinical safety study data by regulatory authorities in EU, US and worldwide.
We are the one provider that covers all aspects of your project
Benefit from our large network of labs and technologies
Eurofins Genomics as part of Eurofins Scientific is a market leader in testing and laboratory services for genomics, discovery pharmacology and clinical studies.
We support from research to application:
Pharma | Diagnostics | Biotechnology
With our globally unrivalled lab network, we support standard and challenging research projects, as well as complex strategies for large interdisciplinary companies.
You are in good company – we are approved by our peers
Eurofins Genomics is a trusted brand
around the globe
We cooperate with 16 of the TOP 20 Big Pharma companies
We cooperate with renowned organisations ranging from small-, medium- and large-scale enterprises to academic institutions. We provide leading expertise and sequencing capabilities that are needed to address some of today’s most important scientific and technical challenges.
We are scientific partners with
We are cooperation partners with
We are scientific partners with
We are cooperation partners with
Your dedicated Oncology Expert
Bernhard Busch, PhD
Senior Oncology Field Specialist
Interesting articels and webinars
Application of genomics solutions in oncology
Digital PCR
NGS AS CLINICAL DIAGNOSTICS TOOL IN ONCOLOGY
ONCOMPASS – TRUSTED PARTNER FOR PERSONALISED CANCER THERAPY
Cancer Ecology
dPCR is used in oncology and enables precise and sensitive cancer diagnostics. Find out how cfDNA in bodily fluids is used for cancer diagnostics by dPCR.
Genome analysis of cancers is used to choose the most effective cancer therapies, called personalised medicine. Learn how NGS is used in diagnostics for oncology.
Personalised cancer therapy is complicated and Oncompass provides navigation to decide for the best-suited therapy.
What do invasive species and metastasis have in common? What is the effect of selective pressure on cancer cells and how does this impact cancer therapy?
Digital PCR
dPCR is used in oncology and enables precise and sensitive cancer diagnostics. Find out how cfDNA in bodily fluids is used for cancer diagnostics by dPCR.
NGS AS CLINICAL DIAGNOSTICS TOOL IN ONCOLOGY
Genome analysis of cancers is used to choose the most effective cancer therapies, called personalised medicine. Learn how NGS is used in diagnostics for oncology.
ONCOMPASS – TRUSTED PARTNER FOR PERSONALISED CANCER THERAPY
Personalised cancer therapy is complicated and Oncompass provides navigation to decide for the best-suited therapy.
ONCOMPASS – TRUSTED PARTNER FOR PERSONALISED CANCER THERAPY
What do invasive species and metastasis have in common? What is the effect of selective pressure on cancer cells and how does this impact cancer therapy?
Festival of Genomics 2021 Webinar
Better than exomes
Better than panels. What are the relative genomic aberrations in tumours? Analyse virtually all cancer-associated genes with one solution: Comprehensive genomic cancer profiling.